These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22610518)

  • 1. Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect.
    Plumb JA; Venugopal B; Oun R; Gomez-Roman N; Kawazoe Y; Venkataramanan NS; Wheate NJ
    Metallomics; 2012 Jun; 4(6):561-7. PubMed ID: 22610518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol.
    Oun R; Plumb JA; Wheate NJ
    J Inorg Biochem; 2014 May; 134():100-5. PubMed ID: 24595010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chemical preformulation study of a host-guest complex of cucurbit[7]uril and a multinuclear platinum agent for enhanced anticancer drug delivery.
    Kennedy AR; Florence AJ; McInnes FJ; Wheate NJ
    Dalton Trans; 2009 Oct; (37):7695-700. PubMed ID: 19759943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cucurbit [7] uril encapsulated cisplatin overcomes resistance to cisplatin induced by Rab25 overexpression in an intraperitoneal ovarian cancer model.
    Gomez-Roman N; McGregor F; Wheate NJ; Plumb JA
    J Ovarian Res; 2015 Sep; 8():62. PubMed ID: 26384969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cucurbit[n]uril binding of platinum anticancer complexes.
    Wheate NJ; Buck DP; Day AI; Collins JG
    Dalton Trans; 2006 Jan; (3):451-8. PubMed ID: 16395444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Targeted Zeolitic Imidazolate Frameworks Drug Delivery System Reversing Cisplatin Resistance to Treat Resistant Ovarian Cancer.
    Xing Y; Jing R; Tang X; Jiang Z
    Int J Nanomedicine; 2024; 19():6603-6618. PubMed ID: 38979533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Cucurbit[7]uril on the Antitumor and Immunomodulating Properties of Oxaliplatin and Carboplatin.
    Pashkina E; Aktanova A; Mirzaeva I; Kovalenko E; Andrienko I; Knauer N; Pronkina N; Kozlov V
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-Guest Interactions between Oxaliplatin and Cucurbit[7]uril/Cucurbit[7]uril Derivatives under Pseudo-Physiological Conditions.
    Wu H; Chen H; Tang B; Kang Y; Xu JF; Zhang X
    Langmuir; 2020 Feb; 36(5):1235-1240. PubMed ID: 31941282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
    Datta S; Misra SK; Saha ML; Lahiri N; Louie J; Pan D; Stang PJ
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8087-8092. PubMed ID: 30038010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of cucurbit[7]uril and cucurbit[8]uril: an exploratory in vitro and in vivo study.
    Uzunova VD; Cullinane C; Brix K; Nau WM; Day AI
    Org Biomol Chem; 2010 May; 8(9):2037-42. PubMed ID: 20401379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
    Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
    J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
    Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
    Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cucurbit[7]uril: an emerging candidate for pharmaceutical excipients.
    Kuok KI; Li S; Wyman IW; Wang R
    Ann N Y Acad Sci; 2017 Jun; 1398(1):108-119. PubMed ID: 28692768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interference with the expression of β-catenin reverses cisplatin resistance in A2780/DDP cells and inhibits the progression of ovarian cancer in mouse model.
    Zhao H; Wei W; Sun Y; Gao J; Wang Q; Zheng J
    DNA Cell Biol; 2015 Jan; 34(1):55-62. PubMed ID: 25211326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Polypeptide-Microtubule Aggregation with Cucurbit[8]uril for Enhanced Cell Apoptosis.
    Zhang YM; Liu JH; Yu Q; Wen X; Liu Y
    Angew Chem Int Ed Engl; 2019 Jul; 58(31):10553-10557. PubMed ID: 31165539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.
    Krieger ML; Eckstein N; Schneider V; Koch M; Royer HD; Jaehde U; Bendas G
    Int J Pharm; 2010 Apr; 389(1-2):10-7. PubMed ID: 20060458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of platinum(II)-based DNA intercalators within cucurbit[6,7,8]urils.
    Kemp S; Wheate NJ; Wang S; Collins JG; Ralph SF; Day AI; Higgins VJ; Aldrich-Wright JR
    J Biol Inorg Chem; 2007 Sep; 12(7):969-79. PubMed ID: 17653578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supramolecular co-encapsulation of a photosensitizer and chemotherapeutic drug in cucurbit[8]uril for potential chemophototherapy.
    Solis-Egaña F; Lavín-Urqueta N; Guerra Díaz D; Mariño-Ocampo N; Faúndez MA; Fuentealba D
    Photochem Photobiol Sci; 2022 Mar; 21(3):349-359. PubMed ID: 35088367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the stability of cucurbit[8]uril-based ternary host-guest complexation in physiological environment and the fabrication of a supramolecular theranostic nanomedicine.
    Wu H; Chen Z; Qi S; Bai B; Ye J; Wu D; Shen J; Kang F; Yu G
    J Nanobiotechnology; 2021 Oct; 19(1):330. PubMed ID: 34670552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.